Extensively drug-resistant tuberculosis in India: A review

Michael, Joy Sarojini; John, T. Jacob
October 2012
Indian Journal of Medical Research;Oct2012, Vol. 136 Issue 4, p599
Academic Journal
Background & objectives: Extensively drug resistant tuberculosis (XDR-TB) has become a new threat for the control of TB in many countries including India. Its prevalence is not known in India as there is no nation-wide surveillance. However, there have been some reports from various hospitals in the country. Methods: We have reviewed the studies/information available in the public domain and found data from 10 tertiary care centres in 9 cities in India. Results: A total of 598 isolates of XDR Mycobacterium tuberculosis have been reported in the studies included. However, the reliability of microbiological methods used in these studies was not checked and thus the XDR-TB data remained invalidated in reference laboratories. Interpretation & conclusions: Systematic surveillance and containment interventions are urgently needed.


Related Articles

  • Global transcriptional profiles of Mycobacterium tuberculosis treated with plumbagin. Ye, Haiqing; Liu, Zengshan; Guo, Aizhen; Liang, Junchao; Guo, Na; Zeng, Fanli; Liu, Liqiang; Li, Lei; Jin, Jing; Wu, Xiuping; Li, Yang; Liu, Mingyuan; Jin, Qi; Yu, Lu // World Journal of Microbiology & Biotechnology;Oct2011, Vol. 27 Issue 10, p2261 

    Mycobacterium tuberculosis ( M. tuberculosis) remains one of the world's most prevalent and serious pathogens, and multiple resistant strains are increasingly widespread. The recent emergence of multidrug-resistant and extensively drug-resistant (XDR-TB) strains has increased the importance of...

  • Incurable TB threatens millennium. Kleiner, Kurt // New Scientist;11/01/97, Vol. 156 Issue 2106, p14 

    Reports on World Health Organization's warning of an outbreak of drug-resistant tuberculosis all over the world. Countries most affected of the disease; Cause of drug-resistant tuberculosis; Prevention of drug-resistant tuberculosis.

  • A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Sambandamurthy, Vasan K.; Wang, Xiaojuan; Chen, Bing; Russell, Robert G.; Derrick, Steven; Collins, Frank M.; Morris, Sheldon L.; Jacobs, William R. // Nature Medicine;Oct2002, Vol. 8 Issue 10, p1171 

    With the advent of HIV and the widespread emergence of drugresistant strains of Mycobacterium tuberculosis, newer control strategies in the form of a better vaccine could decrease the global incidence of tuberculosis. A desirable trait in an effective live attenuated vaccine strain is an ability...

  • Double Infection with a Resistant and Multidrug-Resistant Strain of Mycobacterium tuberculosis. Niemann, Stefan; Richter, Elvira; Rusch-Gerdes, Sabine; Schlaak, Max; Greinert, Ulf // Emerging Infectious Diseases;Sep/Oct2000, Vol. 6 Issue 5, p548 

    An immunocompetent patient was dually infected with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis (TB). The multidrug-resistant strain, which belongs to the W-strain/Beijing family, was first isolated after 3 months of therapy. Inappropriate treatment led to further...

  • Multidrug-Resistant Tuberculosis in Prison Inmates, Azerbaijan. Pfyffer, Gaby E.; Strassle, Anni; van Embden, Jan D.A.; Portaels, Francoise; Rigouts, Leen; Traore, Hamidou; Mathieu, Christine; Mirzoyev, Fuad // Emerging Infectious Diseases;Sep/Oct2001, Vol. 7 Issue 5, p855 

    In a tuberculosis (TB) program in the Central Penitentiary Hospital of Azerbaijan, we analyzed 65 isolates of Mycobacterium tuberculosis by IS6110-based restriction fragment-length polymorphism (RFLP) and spoligo-typing. From 11 clusters associated with 33 patients, 31 isolates had an...

  • Novel Treatment of Meningitis Caused by Multidrug-Resistant Mycobacterium tuberculosis with Intrathecal Levofloxacin and Amikacin: Case Report. Berning, Shaun E.; Cherry, Teresa A.; Iseman, Michael D. // Clinical Infectious Diseases;2/15/2001, Vol. 32 Issue 4, p643 

    Deals with a case of meningitis caused by multidrug-resistant Mycobacterium tuberculosis. Clinical characteristics of the patient; Laboratory test results; Treatment and management.

  • TB: Something Old and Something New. Breindl, Anette // BioWorld Today;9/9/2013, Vol. 24 Issue 172, p2 

    The article discusses research on the drug resistance in Mycobacterium tuberculosum, referencing a study published in the September 1, 2013 issue of "Nature Genetics."

  • ERRATUM.  // Journal of Infectious Diseases;12/1/2004, Vol. 190 Issue 11, p2059 

    Presents a correction to an article on the selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.

  • Genetic susceptibility and resistance to tuberculosis.  // Thorax;Oct2011, Vol. 66 Issue 10, p855 

    The article focuses on a cohort study which aims at investigating the genetic susceptibility and drug resistance associated with Mycobacterium tuberculosis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics